KEEP THE PHILLY PI 100% READER-POWERED

Support Independent Journalism in Philadelphia

HELP THE PHILLY PI DELIVER UNBIASED, COMMUNITY-FOCUSED NEWS

The Philly PI relies on reader support to deliver crucial investigative reporting, breaking news, community safety updates, and transparent tech coverage. Independent journalism requires time, deep research, and absolute editorial freedom—free from paywalls, political influence, or corporate control. We cannot keep our newsroom running without you.

  • 100% READER-FUNDED NEWSROOM

  • NO PAYWALLS OR CORPORATE CONTROL

  • KEEP INDEPENDENT JOURNALISM FREE FOR ALL

LATEST IN SCIENCE & TECH

Italy Deploys an Army of 130,000 Baby Octopuses in ‘War’ Against Invasive Crabs

Italy Deploys an Army of 130,000 Baby Octopuses in ‘War’ Against Invasive Crabs

Illustration made with the help of AI. Credit: ZME Science. Italy is…

Scientists Found an Amazing Reason Some Lava Worlds Can Keep Their Atmospheres Against All Odds

Scientists Found an Amazing Reason Some Lava Worlds Can Keep Their Atmospheres Against All Odds

Worlds like 55 Cancri e seem almost designed to destroy an atmosphere.…

Singapore Is Culling Thousands of Crows While Building the Perfect Habitat for Them

Singapore Is Culling Thousands of Crows While Building the Perfect Habitat for Them

A crow poisoned by a pest control company at Sungei Tengah Lodge…

Bolivian river dolphins anaconda

Bolivian river dolphins sometimes dangle anacondas in their mouths and scientists don’t know why

Not all dolphins live in the oceans. Some can be found swimming…

Panda bears hugging with playful expressions on a red background.

Why Can’t Pandas Get It On? The Answer to Their Poor Sex Lives May Lie in Their Intestines

Poor pandas. While the iconic bear species of China is no longer…

Earth Microbes Could Survive on the Moon’s Poles for Weeks and NASA Scientists Are Worried

Earth Microbes Could Survive on the Moon’s Poles for Weeks and NASA Scientists Are Worried

The next astronauts to walk near the Moon’s south pole will bring…

$0
Raised
0
Donations
$200
Goal
0%
$

The Philly PI site favicon and logo featuring bold white "PI" lettering on a dark blue background.
LIVE
Subscribe
DONATE
Subscribe
SIGN IN
  • Philly Pulse
  • Politics
  • 2026 Elections
  • Business
  • Security
  • Science & Tech
  • Sports
  • Entertainment
  • Lifestyle
  • People
  • Shopping

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • December 2024

Categories

  • 2026 Elections
  • Affiliate Resources
  • AI
  • Ammo & Ballistics
  • Business
  • China
  • Comedy
  • Crime
  • Culture
  • Europe
  • Fact Check
  • Firearm Reviews
  • Game Guides
  • Gaming
  • Gaming PCs
  • Gear & Ballistics
  • Hacking
  • Health
  • History
  • IPO Watch
  • Iran
  • Israel
  • Japan
  • Lifestyle
  • Market Recon
  • Mexico
  • Military & Defense
  • Military History
  • Missing Person
  • Movies
  • News
  • Opinion
  • People
  • Politics
  • Range & Shooting Sports
  • Russia
  • Saudi Arabia
  • Science
  • Security
  • Shopping
  • Somalia
  • Sport
  • Startups
  • Tech
  • Travel
  • Ukraine
  • Uncategorized
  • Venezuela
  • Video
  • World
★
Midterm Elections 2026
Balance of Power
54 Majority Won Senate (51 to win) 44
● Democrats Republicans ●
253 Majority Won House (218 to win) 150
Saturday, Nov 21, 2026
LIVE
Subscribe
Donate
Philly PI
Donate
bitcoin
Bitcoin (BTC) $ 57,931.00 6.20%
ethereum
Ethereum (ETH) $ 1,628.45 6.96%
solana
Solana (SOL) $ 67.48 7.01%
bnb
BNB (BNB) $ 524.17 8.21%
dogecoin
Dogecoin (DOGE) $ 0.052929 7.88%
cardano
Cardano (ADA) $ 0.138703 7.26%
tron
TRON (TRX) $ 0.302741 2.07%
monero
Monero (XMR) $ 444.34 7.78%
litecoin
Litecoin (LTC) $ 38.89 6.95%
kucoin-shares
KuCoin (KCS) $ 5.74 6.39%
binance-bridged-usdc-bnb-smart-chain
Binance Bridged USDC (BNB Smart Chain) (USDC) $ 0.999945 0.02%
jupiter-exchange-solana
Jupiter (JUP) $ 0.209186 7.94%
Philly PI
  • Philly Pulse
  • Politics & World
  • Business
  • Sports
  • Entertainment
Search
  • Philly Pulse
  • Politics & World
  • Business
  • Tech & Science
  • Sports
  • Gaming
  • Shopping
Have an existing account? Sign In
Follow US
© 2026 The Philadelphia Post-Intelligencer.
Shocking New Video Reveals Fiery Crash After SUV Hits U-Haul Building

Shocking New Video Reveals Fiery Crash After SUV Hits U-Haul Building

THEY LIKE VALUE, NOT JUST “YOU” (YouTube – Paul Bryson)…

Meuser Speaks in Support of the Housing 21st Century Act

Meuser Speaks in Support of the Housing 21st Century Act

Critical Ballistic Missiles Strike Kyiv As Western Intelligence Failures Exposed

Dormakaba flaws allow to access major organizations’ doors

Dormakaba flaws allow to access major organizations’ doors

Nvidia-backed Lumentum sold out of AI server parts till 2029

Nvidia-Backed Lumentum Sells Out of AI Server Parts Through 2029

Klein 2-in-1 Adjustable Wrench 5076RT

New Klein Adjustable Wrench is Also a Pass-thru Ratchet

Russia-linked Sandworm APT implicated in major cyber attack on Poland’s power grid

Russia-linked Sandworm APT implicated in major cyber attack on Poland’s power grid

Castlevania: Belmont's Curse Best Weapon Tier List, Rankings, and Relic RecommendationsFind the Castlevania: Belmont's Curse best weapon in our definitive tier list, rankings, and relic guide for every playstyle.2026-10-18

Castlevania: Belmont’s Curse Best Weapon Tier List and Relic Guide

IPO Watch

Bambusa Therapeutics Launches $150 Million IPO

Boston-based clinical-stage biotechnology company Bambusa Therapeutics has launched its proposed $150 million initial public offering. According to its S-1/A filing, the company is offering 9.38 million shares at an estimated price range of $15.00 to $17.00 per share, targeting a valuation of roughly $796.19 million at the $16.00 mid-point. BofA Securities, Evercore ISI, UBS Investment Bank, and Cantor are serving as joint book-runners for the deal, which is expected to price later this week.

Bambusa specializes in developing next-generation, long-acting precision bispecific therapies aimed at treating autoimmune and inflammatory diseases. Its lead product candidate, BBT001, targets core Type 2 inflammation and chronic itch associated with atopic dermatitis, with a Phase 2b trial planned by the end of 2026. The company’s second candidate, BBT002, is currently being evaluated globally for chronic obstructive pulmonary disease (COPD) and chronic rhinosinusitis with nasal polyps, alongside early-stage preclinical programs for inflammatory bowel diseases and autoantibody-driven conditions.

Like many clinical-stage biotechs entering the public markets, Bambusa Therapeutics is currently unprofitable and has not yet generated any commercial product revenue. Proceeds from the offering will help fund the advancement of its expanding clinical pipeline.

Share This Article
Facebook Telegram Threads Copy Link Print
By
Dirk Guntram
October 27, 2026
Share
Picture of Dirk Guntram

Dirk Guntram

All Posts

JOIN THE CONVERSATION

Subscribe
Connect with
Login
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
Notify of
guest
Connect with
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
guest
0 Comments
Oldest
Newest Most Voted

Top stories

zerohedge logo

America's Wile E. Coyote Moment

Authored by Matthew Piepenburg via VonGreyerz.gold, When it comes…

Shocking Video Captures NJ Students Hit By SUV As Classmates React In Outrage

Shocking Video Captures NJ Students Hit By SUV As Classmates React In Outrage

SOUTH JERSEY — Communities across the Delaware Valley are…

zerohedge logo

The Limits Of Control: Why Human Nature Will Defeat China's AI Socialism

Authored by Stu Cvrk via The Epoch Times,Beijing is…

zerohedge logo

Why Might Putin Finally Decide To Bring Ukraine To Its Knees After Nearly Five Years

Authored by Andrew Korybko via Substack, Regardless of why…

The Neoconservative Echo: Inside the World of Marc Thiessen | Philly PI

The Neoconservative Echo: Inside the World of Marc Thiessen

From Bush-era speechwriter to Fox News fixture, a look…

Newegg Reveals Spring 2026 Dominant Prebuilt Gaming PCs and Crucial Hardware Upgrades

Newegg Reveals Spring 2026 Dominant Prebuilt Gaming PCs and Crucial Hardware Upgrades

Spring has officially arrived, and for desktop enthusiasts across…

Russian Defense Ministry Details Strategic Deployment of Automated Anti-Aircraft Systems Against Drones

Russian Defense Ministry Details Strategic Deployment of Automated Anti-Aircraft Systems Against Drones

THEATER OF OPERATIONS: SOUTHERN FRONT / ZAPORIZHIA OBLAST Automated…

Intel Core i9-12900K Alder Lake Benchmarked: See How The New Flagship Dominates

Intel Core i9-12900K Alder Lake Benchmarked: See How The New Flagship Dominates

The desktop processor landscape underwent a seismic shift with…

Critical Debate Clash: Shapiro and Garrity Face Off Over Pennsylvania Gas Tax

Critical Debate Clash: Shapiro and Garrity Face Off Over Pennsylvania Gas Tax

PHILADELPHIA — As Pennsylvania voters weigh their options ahead…

Dimethyl Sulfoxide (DMSO): The Science, Potential, and Regulatory Limits of a Powerful Solvent | Philly PI

Dimethyl Sulfoxide (DMSO): The Science, Potential, and Regulatory Limits of a Powerful Solvent

Executive Summary Dimethyl sulfoxide (DMSO), an organosulfur compound with…

Related Articles

Anthropic Tops SpaceX with $83 IPO, $5 Above Range

By
Dirk Guntram
2 Min Read

Anthropic IPO Set to Make History as First Major AI Frontier Public Offering

By
Dirk Guntram
1 Min Read

vVardis Prices Upsized IPO Below Range and Stock Falls on NYSE

By
Dirk Guntram
2 Min Read

Windward Bio Prices IPO at $17 Mid-Point

By
Dirk Guntram
2 Min Read

Anthropic Unveils Terms for $61.05 Billion IPO

By
Dirk Guntram
2 Min Read

Biotech and Dental Start-Ups Prep IPOs Amid Anthropic Watch

By
Dirk Guntram
1 Min Read

Free Philly PI Newsletter

Brings you a selection of the latest news, trends, insights, and tips from around the world.

You’ve been successfully subscribed to our newsletter!

Philly PI

Sections & Features

  • Philly Pulse
  • Politics & World
  • Business
  • Tech & Science
  • Sports
  • Gaming
  • Shopping


  • Entertainment
  • Tech
  • Health
  • Fact Check
  • Crime Report

In-Focus

  • Iran War
  • Indie Vanguard Awards Hub
  • On air
  • Write for The Philly PI
  • Sign up / Login
  • Donate
  • Advertise
  • Privacy Policy
  • Terms Of Use
  • Subscription Terms
  • Sitemap
  • Philly Pulse
  • Politics & World
  • Business
  • Sports
  • Entertainment

© 2026 The Philadelphia Post-Intelligencer. All Rights Reserved. The Philadelphia Post-Intelligencer is your trusted source for comprehensive and balanced news coverage. With a commitment to integrity and accuracy, we provide in-depth reporting that uncovers the stories that matter most.

The Philly PI Newsletter
  • Daily Stories
  • Stock Arlets
  • Full Acess
Subscribe to our newsletter to get our newest articles instantly!

You’ve been successfully subscribed to our newsletter!

$0
Raised
0
Donations
$200
Goal
0%
$

The Philly PI Newsletter
  • Daily Stories
  • Stock Arlets
  • Full Acess
Subscribe to our newsletter to get our newest articles instantly!

You’ve been successfully subscribed to our newsletter!

$0
Raised
0
Donations
$200
Goal
0%
$

wpDiscuz
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up